Zizant 2MIU Injection

This injectable formulation is primarily used in hospital settings for infections such as ventilator-associated pneumonia, bloodstream infections, urinary tract infections, and complicated intra-abdominal infections when alternative therapies are ineffective or contraindicated. Dosage and duration of therapy should be individualized based on the severity of infection, renal function, and patient response.

Zizant 2MIU Injection is administered via intravenous infusion under strict aseptic conditions. Caution is advised in patients with renal impairment, as dose adjustment may be necessary to minimize the risk of nephrotoxicity and neurotoxicity, which are the most significant adverse effects associated with colistimethate sodium. Monitoring of renal function and neurological status is recommended during therapy.

This product should be used under the supervision of a qualified healthcare professional experienced in the management of serious bacterial infections.